Anti-tumor necrosis factor-α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real-life study.

Fedele F, Martinelli M, Strisciuglio C, Scarpato E, Staiano A, Miele E

Open source

DOI
10.1002/jpn3.70280
Published
2026 Feb
Container
Journal of pediatric gastroenterology and nutrition
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jpn3.70280,
  title = {Anti-tumor necrosis factor-α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real-life study.},
  author = {Fedele F and Martinelli M and Strisciuglio C and Scarpato E and Staiano A and Miele E},
  year = {2026},
  journal = {Journal of pediatric gastroenterology and nutrition},
  doi = {10.1002/jpn3.70280},
  url = {https://doi.org/10.1002/jpn3.70280}
}

RIS

TY  - JOUR
TI  - Anti-tumor necrosis factor-α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real-life study.
AU  - Fedele F
AU  - Martinelli M
AU  - Strisciuglio C
AU  - Scarpato E
AU  - Staiano A
AU  - Miele E
PY  - 2026
JO  - Journal of pediatric gastroenterology and nutrition
DO  - 10.1002/jpn3.70280
UR  - https://doi.org/10.1002/jpn3.70280
ER  - 

APA

F, F., M, M., C, S., E, S., A, S., & E, M. (2026). Anti-tumor necrosis factor-α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real-life study.. Journal of pediatric gastroenterology and nutrition. https://doi.org/10.1002/jpn3.70280

Source records